Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licarbazepine adjunctive therapy for manic episodes in bipolar I disorder
2004-000114-40Phase 3Terminated
- Sponsor
- Novartis
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Licarbazepine + lithium or valproate with Placebo + lithium or valproate (2 arms). Primary endpoint: Change from baseline to endpoint in Young Mania Rating Scale total score. Started Oct 2004; status: terminated.
02
Drugs
licarbazepine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2004-000114-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000114-40.